Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › TX › Sachse › NPI 1871224543
Lab

Sethi Laboratories LLC

Sethi Laboratories LLC was paid $34K by Medicaid between Feb 2023 and May 2023, across 5 billing codes. Its largest line is U0004, 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r — 42% of everything it billed.

33Billing provider infoSETHI LABORATORIES LLC
SACHSE, TX 75048
33aNPI1871224543assigned 06/22/2022
28Total paid$34K
24GClaims1,347
24DCodes billed5
24AFirst – last monthFeb 2023 – May 2023
Compared with peers

Next to other Clinical Medical Laboratory providers in Texas

Rank by total paid#200 of 436
Median peer was paid$17K
This provider vs. median2.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$5.0K$10K$15K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20231,347$34K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 42% 279 201 $14K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 28% 443 273 $10K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 14% 280 202 $5K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 12% 251 203 $4K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 3.5% 94 77 $1K

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMARTINEZ, BEATRIS (MANAGING DIRECTOR)